^
Contact us  to learn more about
our Premium Content:  News alerts, weekly reports and conference planners
GENE:

MIR203A (MicroRNA 203a)

i
Other names: MIR203A, MicroRNA 203a, Hsa-MiR-203a-3p, MicroRNA 203, Hsa-Mir-203, Hsa-Mir-203a, MIMAT0031890, MIMAT0000264, MI0000283, MiRNA203, Mir-203a, MIRN203, MiR-203, MIR203A, RF00696
Associations
5d
The efferocytosis-related genes of SLC26A6, TYRO3, and PDK4 have been identified as predictors of prognosis in hepatocellular carcinoma and are associated with the immune status. (PubMed, Int J Med Sci)
There were 61 drugs with significant differences in IC50 between the high and low risk groups, such as BI.2536 and PD-173074...We identified three prognostic genes associated with efferocytosis in HCC and integrated them into a risk prognostic model. These genes not only serve as signatures for predicting HCC prognosis but also offer insights into the treatment of HCC.
Journal • IO biomarker
|
CD4 (CD4 Molecule) • NUTM2A (NUT Family Member 2A) • PDK4 (Pyruvate Dehydrogenase Kinase 4) • MIR203A (MicroRNA 203a)
|
BI2536
9d
Novel Prognostic and Predictive miRNA Biomarkers Shape the Landscape of T Cell Dysfunction in Cancer. (PubMed, J Cell Mol Med)
In summary, our study highlights the pivotal role of miRNA biomarkers in shaping the landscape of T cell dysfunction across cancers. These miRNAs serve as both prognostic indicators and predictive tools, enabling accurate classification of TCD severity and offering new avenues for therapeutic exploration and patient stratification in cancer immunotherapy.
Journal • IO biomarker
|
MIR200B (MicroRNA 200b) • MIR200A (MicroRNA 200a) • MIR141 (MicroRNA 141) • MIR203A (MicroRNA 203a) • MIR214 (MicroRNA 214)
2ms
RNA-based therapies for colorectal cancer: targeting the β-catenin pathway via microbiota -modulated miRNAs. (PubMed, Front Mol Biosci)
It also covers microbiota-host interactions, including bidirectional links between gut microbes and miRNAs, effects on intestinal homeostasis, and microbial metabolites that alter miRNA expression. Recent advances in RNA-based therapeutic strategies and progress in clinical trials are included to frame the current translational relevance.
Review • Journal
|
MYC (V-myc avian myelocytomatosis viral oncogene homolog) • PTEN (Phosphatase and tensin homolog) • MIR21 (MicroRNA 21) • MIR200C (MicroRNA 200c) • MIR135B (MicroRNA 135b) • MIR145 (MicroRNA 145) • MIR203A (MicroRNA 203a)
2ms
Phillyrin ameliorates sepsis via targeting microRNA-203a-mediated caspase-4/caspase-11/caspase-B downregulation to suppress endothelial pyroptosis. (PubMed, Phytomedicine)
These data identify the miR-203a-CASP4/11/B axis as a critical mediator of endothelial pyroptosis in sepsis. PHN attenuates sepsis by upregulating miR-203a to inhibit CASP4/11/B-dependent pyroptosis. Therefore, PHN warrants further investigation as a potential therapeutic agent for sepsis.
Journal
|
CASP4 (Caspase 4) • MIR203A (MicroRNA 203a) • CASP1 (Caspase 1)
2ms
The role of PAQR3 in cancer progression - Molecular regulation, signaling pathways, and clinical implications: A review. (PubMed, Biomol Biomed)
Progesterone and adiponectin receptor 3 (PAQR3) is a Golgi-localized seven-transmembrane protein that anchors rapidly accelerated fibrosarcoma kinase (Raf) and suppresses rat sarcoma/rapidly accelerated fibrosarcoma/mitogen-activated protein kinase kinase/extracellular signal-regulated kinase (Ras/Raf/MEK/ERK) signaling, thereby influencing cellular proliferation, differentiation, and metastasis...These effects are modulated by upstream regulators, including microRNA-543 (miR-543), circular RNA 0043280/microRNA-203a-3p (circ_0043280/miR-203a-3p), microRNA-15b (miR-15b), human epidermal growth factor receptor 2 (HER2), 5-aza-2'-deoxycytidine (5-Aza-CdR), autophagy-related 7 (ATG7), and damage-specific DNA binding protein 2 (DDB2). In conclusion, PAQR3 functions as a tumor suppressor and holds potential as a prognostic biomarker. Targeting PAQR3-related pathways may provide new therapeutic opportunities.
Review • Journal
|
HER-2 (Human epidermal growth factor receptor 2) • TP53 (Tumor protein P53) • MIR543 (MicroRNA 543) • DDB2 (Damage Specific DNA Binding Protein 2) • ATG7 (Autophagy Related 7) • MIR15B (MicroRNA 15b) • MIR203A (MicroRNA 203a)
2ms
Differential Circulating miRNA Responses to PM Exposure in Healthy and Diabetes Mellitus Patients: Implications for Lung Cancer Susceptibility. (PubMed, Int J Mol Sci)
In an independent clinical cohort, only miR-542-3p differed significantly between lung-cancer patients and healthy controls. These findings indicate that PM exposure reconfigures circulating miRNA, exosomal, and cytokine profiles, and that DM modifies these responses, highlighting miR-542-3p and miR-29a-3p as environmentally responsive and disease-relevant biomarker candidates.
Journal
|
CXCL8 (Chemokine (C-X-C motif) ligand 8) • MIR203A (MicroRNA 203a) • MIR29A (MicroRNA 29a) • MIR542 (MicroRNA 542)
3ms
Differentially Expressed Genes Associated with the Development of Cervical Cancer. (PubMed, Int J Mol Sci)
The publicly available microarray datasets, including GSE39001, GSE9750, GSE7803, GSE6791, GSE63514, and GSE52903 in combination with bioinformatics database predictions, were used to identify differential expression genes, potential biomarkers, and therapeutic targets for cervical cancer; additionally, we undertook bioinformatic analysis to determine gene ontology and possible miRNA targets related to our DEGs...Interestingly, hub proteins KIF4A, NUSAP1, BUB1B, CEP55, DLGAP5, NCAPG, CDK1, MELK, KIF11, and KIF20A were found to be potentially regulated by several miRNAs, including miR-107, miR-124-3p, miR-147a, miR-16-5p, miR-34a-5p, miR-34c-5p, miR-126-3p, miR-10b-5p, miR-23b-3p, miR-200b-3p, miR-138-5p, miR-203a-3p, miR-214-3p, and let-7b-5p. The relationship between these genes highlights their potential as candidate biomarkers for further research in treatment, diagnosis, and prognosis.
Journal
|
TP53 (Tumor protein P53) • TOP2A (DNA topoisomerase 2-alpha) • RAD51 (RAD51 Homolog A) • MIR200B (MicroRNA 200b) • MIR34A (MicroRNA 34a-5p) • RAD51AP1 (RAD51 Associated Protein 1) • NUSAP1 (Nucleolar and Spindle Associated Protein 1) • ELF3 (E74 Like ETS Transcription Factor 3) • FOXM1 (Forkhead Box M1) • MELK (Maternal Embryonic Leucine Zipper Kinase) • CDK1 (Cyclin-dependent kinase 1) • KIF11 (Kinesin Family Member 11) • MIR126 (MicroRNA 126) • MIR16 (MicroRNA 16) • MIR23b (MicroRNA 23b) • NCAPG (Non-SMC Condensin I Complex Subunit G) • PLOD2 (procollagen-lysine,2-oxoglutarate 5-dioxygenase 2) • BUB1B (BUB1 Mitotic Checkpoint Serine/Threonine Kinase B) • CEP55 (Centrosomal Protein 55) • CXCL14 (C-X-C Motif Chemokine Ligand 14) • E2F1 (E2F transcription factor 1) • KIF20A (Kinesin Family Member 20A) • KIF4A (Kinesin Family Member 4A) • MCM2 (Minichromosome maintenance complex component 2) • MCM5 (Minichromosome Maintenance Complex Component 5) • MIR10B (MicroRNA 10b) • MIR138 (MicroRNA 138) • MIR203A (MicroRNA 203a) • MIR214 (MicroRNA 214) • MIRLET7B (MicroRNA Let-7b) • RELA (RELA Proto-Oncogene) • RFC4 (Replication Factor C Subunit 4) • MIR124-3 (MicroRNA 124-3)
3ms
MicroRNAs as Diagnostic and Prognostic Biomarkers in Melanoma and Non-Melanoma Skin Cancers: An Updated Review. (PubMed, Diagnostics (Basel))
Overall, current evidence supports miRNAs as promising diagnostic, prognostic, and predictive biomarkers in cutaneous oncology. Standardized methodologies and large-scale validation remain essential for their integration into routine clinical practice.
Review • Journal
|
BRAF (B-raf proto-oncogene) • MIR34A (MicroRNA 34a-5p) • MIR182 (MicroRNA 182) • MIR18A (MicroRNA 18a) • MIR31 (MicroRNA 31) • MIR375 (MicroRNA 375) • MIR128 (MicroRNA 128) • MIR145 (MicroRNA 145) • MIR181A1 (MicroRNA 181a-1) • MIR203A (MicroRNA 203a) • MIR205 (MicroRNA 205) • MIR383 (MicroRNA 383)
|
BRAF mutation
3ms
Oncogenic Function of miR-182-5p Versus Tumor-Suppressive Activities of miR-203, miR-150-5p, and miR-139-5p via Target Gene Regulation in Colon Cancer Metastasis. (PubMed, Iran J Pharm Res)
Mechanistically, miR-182-5p enhanced metastasis via ANLN and PDE4D regulation, whereas miR-203, miR-150-5p, and miR-139-5p suppressed metastasis through PDE4D, NEGR1, and ATP11A pathways, respectively. These results highlight the opposing roles of miR-182-5p and the tumor-suppressive miRNAs in CRC metastasis and suggest their potential as biomarkers and therapeutic targets.
Journal
|
MIR139 (MicroRNA 139) • MIR182 (MicroRNA 182) • ANLN (Anillin Actin Binding Protein) • MIR150 (MicroRNA 150) • MIR203A (MicroRNA 203a)
3ms
The Activation of miR-203a by SFRP4 Micropeptides Targets Epithelial-Mesenchymal Transition and Autophagy in Ovarian Cancer Stem Cells. (PubMed, Mol Carcinog)
Furthermore, miR-203a expression upon micropeptide treatment resulted in the increased levels of E-cad and decreased levels of N-cad, Snail and Twist, indicating reversal of EMT along with the significant reduction in migratory potential of ovarian CSCs. Our findings for the first time indicated the possible role of miR-203a in regulating autophagy in ovarian CSCs, and reactivation of miR-203a by SFRP4 micropeptides was sufficient to halt the autophagic machinery in ovarian CSCs.
Journal
|
MIR203A (MicroRNA 203a) • SFRP4 (Secreted frizzled-related protein 4)
4ms
MiR-125b-5p and miR-100-5p as Biomarkers and therapeutic targets for the prevention of particulate matter-induced non-smoker lung cancer. (PubMed, PLoS One)
These findings underscore the critical roles of miR-125b-5p and miR-100-5p in PM-associated lung cancer progression and their potential as biomarkers and therapeutic targets. This study highlights distinct mechanisms of lung carcinogenesis in smokers and non-smokers, providing a foundation for targeted interventions in PM-associated lung cancer.
Journal
|
MIR100 (MicroRNA 100) • MIR199A1 (MicroRNA 199a-1) • MIR199A (MicroRNA 199a) • MIR203A (MicroRNA 203a)
5ms
Circulating levels of microRNAs 126-5p, 150-5p, 214-3p, and 452-5p decrease following splenectomy in dogs with hemangiosarcoma. (PubMed, Am J Vet Res)
MiR-126-5p, miR-150-5p, miR-214-3p, and miR-452-5p all showed a decrease in expression at at least one timepoint following splenectomy. These miRNAs have been previously shown to have roles in angiogenesis and pathways known to be involved in the pathogenesis of hemangiosarcoma and may be prospective targets for a minimally invasive diagnostic panel for the presence of splenic hemangiosarcoma.
Journal
|
MIR543 (MicroRNA 543) • MIR126 (MicroRNA 126) • MIR16 (MicroRNA 16) • MIR494 (MicroRNA 494) • MIR497 (MicroRNA 497) • MIR150 (MicroRNA 150) • MIR203A (MicroRNA 203a) • MIR214 (MicroRNA 214) • MIR93 (MicroRNA 93)